Information de reference pour ce titreAccession Number: | 00003439-200803000-00015.
|
Author: | Shapiro, Alexandra 1; Matheny, Michael 1; Zhang, Yi 1,2; Tumer, Nihal 1,2,3; Cheng, Kit-Yan 1; Rogrigues, Enda 1; Zolotukhin, Sergei 4; Scarpace, Philip J. 1,3
|
Institution: | From the (1)Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, Florida; and (2)Department of Veterans Affairs Medical Center, Gainesville, Florida; and (3)Department of Aging and Geriatrics, University of Florida College of Medicine, Gainesville, Florida; and the (4)Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida
|
Title: | Synergy Between Leptin Therapy and a Seemingly Negligible Amount of Voluntary Wheel Running Prevents Progression of Dietary Obesity in Leptin-Resistant Rats.[Article]
|
Source: | Diabetes. 57(3):614-622, March 2008.
|
Abstract: | OBJECTIVE: We examined whether chronic leptin treatment of diet-induced obese rats promotes or alleviates the susceptibility to continued high-fat feeding. Second, we examined if voluntary wheel running is beneficial in reducing the trajectory of weight gain in high-fat-raised leptin-resistant rats.
RESEARCH DESIGN AND METHODS: Sprague-Dawley rats were fed a standard diet or a high-fat diet for 5 months, and then hypothalamic leptin overexpression was induced through central administration of adeno-associated virus-encoding leptin while continuing either the standard or high-fat diet. Two weeks later, half of the rats in each group were provided access to running wheels for 38 days while being maintained on either a standard or high-fat diet.
RESULTS: In standard diet-raised rats, either wheel running or leptin reduced the trajectory of weight gain, and the combined effect of both treatments was additive. In high-fat-raised leptin-resistant rats, leptin overexpression first transiently reduced weight gain but then accelerated the weight gain twofold over controls. Wheel running in high-fat-raised rats was sixfold less than in standard diet-raised rats and did not affect weight gain. Surprisingly, wheel running plus leptin completely prevented weight gain. This synergy was associated with enhanced hypothalamic signal transducer and activator of transcription (STAT) 3 phosphorylation and suppressor of cytokine signaling 3 expression in wheel running plus leptin compared with leptin-treated sedentary high-fat counterparts. This enhanced STAT3 signaling associated with the combination treatment occurred only in high-fat-raised, leptin-resistant rats and not in standard diet-raised, leptin-responsive rats.
CONCLUSIONS: Chronic leptin treatment in diet-induced obese rats accelerates dietary obesity. However, leptin combined with wheel running prevents further dietary weight gain. Thus, this combination therapy may be a viable antiobesity treatment.
(C) 2008 by the American Diabetes Association, Inc.
|
References: | 1. Ahima RS, Flier JS: Leptin. Annu Rev Physiol 62:413-437, 2000
2. Scarpace PJ, Matheny M, Zhang Y, Tumer N, Frase CD, Shek EW, Hong B, Prima V, Zolotukhin S: Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats. Neuropharmacology 42:548-561, 2002
3. Wilsey J, Zolotukhin S, Prima V, Scarpace PJ: Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 285:R1011-R1020, 2003
4. Scarpace PJ, Matheny M, Tumer N, Cheng KY, Zhang Y: Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats. Diabetologia 48:1075-1083, 2005
5. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314, 1995
6. Widdowson PS, Upton R, Buckingham R, Arch J, Williams G: Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes 46:1782-1785, 1997
7. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 94:8878-8883, 1997
8. Slentz CA, Duscha BD, Johnson JL, Ketchum K, Aiken LB, Samsa GP, Houmard JA, Bales CW, Kraus WE: Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE: a randomized controlled study. Arch Intern Med 164:31-39, 2004
9. Flores MB, Fernandes MF, Ropelle ER, Faria MC, Ueno M, Velloso LA, Saad MJ, Carvalheira JB: Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 55:2554-2561, 2006
10. Levin BE, Dunn-Meynell AA: Chronic exercise lowers the defended body weight gain and adiposity in diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 286:R771-R778, 2004
11. Scarpace PJ, Matheny M, Zhang Y, Shek EW, Prima V, Zolotukhin S, Tumer N: Leptin-induced leptin resistance reveals separate roles for the anorexic and thermogenic responses in weight maintenance. Endocrinology 143:3026-3035, 2002
12. Berger I, Fitzgerald DJ, Richmond TJ: Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22:1583-1587, 2004
13. Urabe M, Nakakura T, Xin KQ, Obara Y, Mizukami H, Kume A, Kotin RM, Ozawa K: Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J Virol 80:1874-1885, 2006
14. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N: Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973-985, 1999
15. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ, Jr, Chiodo VA, Phillipsberg T, Muzyczka N, Hauswirth WW, Flotte TR, Byrne BJ, Snyder RO: Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28:158-167, 2002
16. Scarpace PJ, Matheny M, Tumer N: Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 104:1111-1117, 2001
17. Unger RH: Leptin physiology: a second look. Regul Pept 92:87-95, 2000
18. Wake DJ, Walker BR: Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity. Endocrine 29:101-108, 2006
19. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS: Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1:445-450, 1998
20. Scarpace PJ, Matheny M, Zolotukhin S, Tumer N, Zhang Y: Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II. Neuropharmacology 45:211-219, 2003
21. Scarpace PJ, Matheny M, Moore RL, Tumer N: Impaired leptin responsiveness in aged rats. Diabetes 49:431-435, 2000
22. Scarpace PJ, Matheny M, Shek EW: Impaired leptin signal transduction with age-related obesity. Neuropharmacology 39:1872-1879, 2000
23. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:1827-1832, 2000
24. Martin RL, Perez E, He YJ, Dawson R Jr, Millard WJ: Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein downregulation. Metabolism 49:1479-1484, 2000
25. Wilsey J, Scarpace PJ: Caloric restriction reverses the deficits in leptin receptor protein and leptin signaling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J Endocrinol 181:297-306, 2004
26. Wilsey J, Matheny MK, Scarpace PJ: Oral vanadium enhances the catabolic effects of central leptin in young adult rats. Endocrinology 147:493-501, 2006
27. Krebs DL, Hilton DJ: SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378-387, 2001
28. Wisse BE, Ogimoto K, Morton GJ, Williams DL, Schwartz MW: Central interleukin-1 (IL1) signaling is required for pharmacological, but not physiological, effects of leptin on energy balance. Brain Res 1144:101-106, 2007
29. Nonogaki K: New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533-549, 2000
30. Carmen GY, Victor SM: Signalling mechanisms regulating lipolysis. Cell Signal 18:401-408, 2006
31. Mark AL, Correia ML, Rahmouni K, Haynes WG: Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20:1245-1250, 2002
32. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS: Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90, 2003
33. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170, 2001
34. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR: Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53:931-938, 2004
35. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ: 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A 94:14924-14929, 1997
|
Language: | English.
|
Document Type: | ORIGINAL ARTICLE: Obesity Studies.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0012-1797
|
NLM Journal Code: | e8x, 0372763
|
Annotation(s) | |
|
|